^
Association details:
| Biomarker: | NSD3 overexpression |
|---|---|
| Cancer: | Breast Cancer |
| Drug: | LY2109761 (TGF-β R2 kinase inhibitor, TGF-β RI kinase inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Title:
High WHSC1L1 Expression Reduces Survival Rates in Operated Breast Cancer Patients with Decreased CD8+ T Cells: Machine Learning Approach
Published date:
07/05/2021
Excerpt:
we analyzed the drug sensitivity of 50 breast cancer cell lines according to WHSC1L1 expression. We found five anticancer drugs that most effectively reduced the growth of breast cancer cells with high WHSC1L1 expression: VX-11e, CZC24832, LY2109761, oxaliplatin and erlotinib
DOI:
10.3390/jpm11070636
